Understanding Semaglutide and Compounded Semaglutide Semaglutide is the active ingredient in the brand-name medications Ozempic and Wegovy and part of the GLP-1 receptor agonist drug class
DU PLESSIS J
Fake versions of the devices, which are not approved in the U.S., have also been found in the United Kingdom
Zepbound and Mounjaro are the brands of a drug called tirzepatide
Metabolic syndrome, characterized by abdominal obesity, elevated triglycerides, low HDL-C, hypertension, and insulin resistance, confers increased cardiovascular risk
Although hard numbers on how many people are using compounded versions of brand-name medications are notoriously difficult to find, Menon told me that pharmaceutical companies believe the market for these copycat drugs is fairly significant in size. Some of the really big telehealth companies have partnered directly with pharmaceutical companies to get branded versions of the drugs, Menon said